Reckitt Likely To Shed SSL Brands As Profits Trickle In
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser's acquisition of SSL has yet to produce sizeable returns for the company, leading the firm to consider spinning off some acquired brands, company officials said.
You may also be interested in...
Reckitt Continues Asian Push With $724M Paras Purchase
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.
Amid Growth, Reckitt To Launch Mucinex In Emerging Markets Ahead of EU
Emerging markets, the key driver for Reckitt Benckiser's nearly 20% net income growth, will be crucial in the firm's launch of Mucinex decongestants outside the U.S.
Reckitt Would Add Durex, Scholl Brands With SSL Acquisition
Reckitt Benckiser moves again to grow its consumer products business, particularly in Asian markets, with an offer to acquire Durex condoms and Scholl foot care products manufacturer SSL International